Free Shipping Canada-wide on orders over $149.
Free Shipping Canada-wide on orders over $149.
Lab X Peptides stands behind this next-generation triple-agonist peptide with a commitment to uncompromising quality and research integrity. Widely studied in metabolic research, all peptides are sourced through WHO/GMP and ISO 9001:2015 certified manufacturing partners to ensure exceptional purity and consistency. Each batch undergoes rigorous quality control testing to maintain accuracy and reliability for research applications. LabX Peptides prioritizes transparent standards and dependable sourcing so researchers can work with complete confidence.
FOXO4-DRI 10mg is a D-retro-inverso research peptide designed for controlled laboratory study of the interaction between forkhead box O4 (FOXO4) and the tumor-suppressor protein p53.
Preclinical research uses FOXO4-DRI to investigate FOXO4–p53 signaling, cellular senescence, apoptosis pathways, and tissue-homeostasis models. The D-retro-inverso design is studied for its stability and biological activity in experimental systems.
Each vial contains 10mg of lyophilized FOXO4-DRI peptide. Lab tested for identity and purity.
For laboratory research use only. Not for human consumption, veterinary use, diagnostic use, or medical treatment.
Orders are processed promptly and shipped through trusted carriers to ensure timely, secure, and dependable delivery.